MORE than 30 drugs in current clinical use, other than those used in anesthesia, may interfere with neuromuscular transmission. This complication of drug therapy is unusual but has been well documented; over 200 cases have been reported.1 Awareness of the possibility of such an effect is important, since failure to recognize that a drug is responsible for, or is contributing to, a myasthenic syndrome may lead to unnecessary morbidity and even to a fatal outcome in what is potentially a reversible condition. Although clinically manifest neuromuscular blockade is uncommon, subclinical involvement is probably more frequent than is generally appreciated.Clinical . . .
No takes yet. Share an insight, caveat, or question.
Koch‐Weser et al. (1979) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: